Register Login

Connect with:

Login with Facebook Login with Google Login with Twitter Login with LinkedIn

Login with your site account

Connect with:

Login with Facebook Login with Google Login with Twitter Login with LinkedIn

Lost your password?

Not a member yet? Register now

For questions or comments: (504) 267-7789 info@pine-biotech.com

T-BioInfo in EducationT-BioInfo in Education
  • Home
  • Courses
    • Introduction to Bioinformatics
    • Transcriptomics 1
    • Transcriptomics 2
    • Transcriptomics 3
    • Genomics 1
    • Metagenomics 1
    • More Courses
    • Specialization
    Metagenomics

    Metagenomics

    Free
    Read More
  • Specializations
    • Oncology
    • Immunology
    • Virology
    • Neurology
    • Agrotechnology
  • Events
  • Projects
    • Patient Derived Xenograft: Transcriptomic Biomarkers of Breast Cancer
    • Analysis of Changing Immune Response in Cancer
    • Modeling Precision Medicine: Selecting Best Treatment Options For Patients Using “OMICS” Data
  • About Us
  • FAQs
  • Blog
  • Contact
    • Home
    • Courses
      • Introduction to Bioinformatics
      • Transcriptomics 1
      • Transcriptomics 2
      • Transcriptomics 3
      • Genomics 1
      • Metagenomics 1
      • More Courses
      • Specialization
      Metagenomics

      Metagenomics

      Free
      Read More
    • Specializations
      • Oncology
      • Immunology
      • Virology
      • Neurology
      • Agrotechnology
    • Events
    • Projects
      • Patient Derived Xenograft: Transcriptomic Biomarkers of Breast Cancer
      • Analysis of Changing Immune Response in Cancer
      • Modeling Precision Medicine: Selecting Best Treatment Options For Patients Using “OMICS” Data
    • About Us
    • FAQs
    • Blog
    • Contact

    Patient Derived Xenograft: Transcriptomic Biomarkers of Breast Cancer

    • Posted by sahil
    • Date January 31, 2018
    START PROJECT
    ONCOLOGY SPECIALIZATION TRACK
    • Project Summary
    • What You will Learn
    • Project Team

    Project Summary

    Animal models have been widely used for experimentation and the mouse is a signature organism that is present in many labs. In this project, we will learn about the technological advances that allow us to improve the animal models in ways that enable discovery of biomarkers that could be more relevant to a disease detected in humans.

    In a PDX model, a human tumor sample is implanted into immune-deficient mice, and human stroma is generally replaced by mouse stroma. Recently it was recognized that this approach also provides a simple and reliable method for separation of tumor and stroma expression profiles. The completeness of replacement can be evaluated by measuring the expression levels of human stromal markers, such as CAF markers fibroblast activation protein alpha (FAP) and chondroitin sulfate proteoglycan 4 (CSPG4). Thus, sequencing PDX-samples and measuring expression level of genes we can consider positively expressed human genes as genes expressed in tumor cells, and positively expressed mouse genes as genes expressed in stroma cells. These types of studies have their own limitations, but allow extensive characterization of human or even a specific patient tissue behavior in a lab environment.

    START PROJECT

    What You will Learn

    This is an exciting project for those interested in translational research and biomarker use in cancer subtype characterization and associated technical skills needed to properly process data, eliminate technical issues and use machine learning tools to extract meaningful insights from complex molecular datasets.

    Key Concepts:

    Tumor Microenvironment – extracellular matrix, immune system and tumor cells: In the tumour microenvironment, cancer cells directly interact with both the immune system and the stroma. It is firmly established that the immune system, historically believed to be a major part of the body’s defence against tumour progression, can be reprogrammed by tumour cells to be ineffective, inactivated, or even acquire tumour promoting phenotypes. Likewise, stromal cells and extracellular matrix can also have pro- and anti-tumour properties.

    Breast cancer subtypes: This project will cover several types of cancer subtypes that are often times determined by the origin of the tumor cell type. The subtypes can be hard to determine and categorize, but recent studies in gene expression have led to a number of methods that leverage gene expression for this purpose.

    Patient-derived Xenograft Models: PDX models are animals that were modified to be used as an environment for human tumors that can be studied.

    Drug Efficacy Studies: In drug discovery, the challenge is to identify an active molecule or intervention that is effective and at the same time not too toxic to normal cells that it ultimately treats disease. Efficacy can be defined as the performance of an intervention under ideal and controlled circumstances, whereas effectiveness refers to its performance under ‘real-world’ conditions.

    Practical Skills:

    RNA-seq: Next Generation Sequencing data has specific characteristics requiring an appropriate method to process the raw data and turn it into a useful resource we can study. The short reads need to be aligned to a reference genome, accurately measured and put into readable form.

    Generating a table of gene expression using the RNA-Seq by Expectation Maximization (RSEM) method takes the prepared data that is annotated with position information extracted from a reference and quantified using a statistical method that converts the “count” of reads with various lengths into a “level of expression” number for the whole gene or isoform.

    Classification and Feature Selection: using the gene expression table we will learn how to train a statistical model to classify a dataset using an annotated “training dataset” and use feature selection to identify the minimum number of features that are most informative in this process.

    Project Team

    Collaboration Project

    This project was created in collaboration with the Tauber Bioinformatics Research Center at the University of Haifa.

    Dario Ghersi

    Dr. Dario Ghersi

    Biomedical Informatics
    lucio-miele

    Dr. Lucio Miele

    Genetics Department Head
    JackLeBien

    Jack LeBien

    Data Scientist
    Screenshot 2017-08-03 12.58.17

    Dr. Saaket Varma

    Biomedical Data Scientist
    • Share:
    sahil

    Next post

    Analysis of Changing Immune Response in Cancer
    February 20, 2018

    You may also like

    • t-bioinfo interface video
      Start using the T-BioInfo platform (introduction to the T-Bioinfo interface)
      19 April, 2018
    • April17 Bioinformatics Workshop at UNMC
      Mastering RNA-Seq: A Critical Approach To Transcriptomic Data Analysis
      15 April, 2018
    • UNL-tv-screen-poster-April20
      A critical approach to transcriptomic data analysis
      9 April, 2018

    Projects

    • Modeling Precision Medicine: Selecting Best Treatment Options For Patients Using “OMICS” Data

    • Analysis of Changing Immune Response in Cancer

    • Patient Derived Xenograft: Transcriptomic Biomarkers of Breast Cancer


    (504) 267-7789
    info@pine-biotech.com

    Company

    • About Us
    • Blog
    • Contact

    Links

    • FAQs
    • Events

    Support

    • Forums
    • Workshops

    Copyright © 2017-18. Pine Biotech All Rights Reserved.

    • Privacy
    • Terms
    • Sitemap

    Become an Instructor

    if you are a professor, industry expert or administrator, you can help us make this program work. These could be your students, potential hires, or colleagues.

    Get Started